An increasing trend for peripheral expansion of expanded clonotypes between cycle 1 and cycle 7/progression compared to PFS was observed, and a statistically significant trend was observed between cycle 1 and cycle 17/progression compared to PFS ( Figure 5 E).
← all excerpts
PD-1 blockade plus cisplatin-based chemotherapy in patients with small cell/neuroendocrine bladder and prostate cancers.
1
—
—